Revertants of Mouse Cells Transformed by Murine Sarcoma Virus: flat Variants without a Rescuable Sarcoma Virus from a Clone of BALB/3T3 Transformed by Kirsten MSV
Clonal subline of Kirsten murine sarcoma virus (Ki-MSV)-transformed non-producer BALB/3T3 (Ki-BALB) cells spontaneously produced flat variants with some properties of non-transformed cells at frequencies of 0.01 to 0.001. Such variants were epithelioid, contact-inhibited, grew to low saturation density and exhibited variable cloning efficiences in soft agar. They demonstrated no murine leukaemia group-specific antigen(s), no reverse transcriptase activity, and no infectious virus, but were agglutinable by concanavalin A. Murine leukaemia virus (MuLV) was induced after 5-iododeoxyuridine (IUDR) treatment from both the flat variants and from the parental Ki-BALB cells. However, Ki-MSV could not be rescued from these flat variants by superinfection with MuLV, nor induced by treatment with IUDR. The state of reversion was stable, revealing no back-transformation during 30 to 40 subcultures. The tumourigenicity of the flat variants in BALB/c mice was markedly reduced (actually undetectable) compared to that of the Ki-BALB cells. All flat variants were susceptible to MSV and MuLV infection. The loss of the transformed phenotype in spontaneous flat variants was associated with a decrease in chromosome number to a level similar to BALB/3T3 cells. These observations suggest that these revertants may have lost some or all of the Ki-MSV genome.
AaronsonS. A.1971; Chemical induction of focus-forming virus from nonproducer cells transformed murine sarcoma virus. Proceedings of the National Academy of Sciences of the United States of America 68:3069–3072
AaronsonS. A.,
StephensonJ. R.1973; Independent segregation of loci for activation of biologically distinguishable RNA C-type viruses in mouse cells. Proceedings of the National Academy of Sciences of the United States of America 70:2055–2058
AaronsonS. A.,
TodaroG. J.1968; Development of 3T3-like lines from BALB/c mouse embryo cultures: transformation susceptibility to SV40. Journal of the Cell Physiology 72:141–142
AaronsonS. A.,
TodaroG. J.,
ScolnickE. M.1971; Induction of murine C-type viruses from clonal lines of virus-free BALB/3T3 cells. Science, New York 174:157–159
AaronsonS. A.,
WeaverC. A.1971; Characterization of murine sarcoma virus (Kirsten) transformation of mouse and human cells. Journal of General Virology 13:245–252
AokiT.,
TodaroG. J.1973; Antigenic properties of endogenous type-C viruses from spontaneously transformed clones of BALB/3T3. Proceedings of the National Academy of Sciences of the United States of America 70:1598–1602
BassinR. H.,
TuttleN.,
FischingerP. J.1970; Isolation of murine sarcoma virus transformed mouse cells which are negative for leukemia virus from agar suspension cultures. International Journal of Cancer 6:95–107
Duc-NguyenH.,
RosenblumE. N.,
ZeigelR. F.1966; Persistent infection of a rat kidney cell line with Rauscher leukemia virus. Journal of Bacteriology 92:1133–1140
FischingerP. J.,
MooreC. O.,
O’connorT. E.1969; Isolation and identification of a helper virus found in the Moloney sarcoma-leukemia virus complex. Journal of the National Cancer Institute 42:605–622
FischingerP. J.,
NomuraS.,
PeeblesP. T.,
HaapalaD. K.,
BassinR. H.1972; Reversion of murine sarcoma transformed mouse cells: variants without a rescuable sarcoma virus. Science, New York 176:1033–1035
FischingerP. J.,
NomuraS.,
Tuttle-FullerN.,
DunnJ. K.1974; Revertants of mouse cells transformed by murine sarcoma virus. III. Metastable expression of virus functions in revertants retransformed by murine sarcoma virus. Virology 59:217–229
GazdarA. F.,
StullH. B.,
ChopraH. C.,
IkawaY.1974; Properties of flat variants of murine sarcoma virus transformed nonproducer cells isolated after high-temperature passage. International Journal of Cancer 13:219–226
GreenbergerJ. S.,
AaronsonS. A.1974; Morphologic revertants of murine sarcoma virus transformed nonproducer BALB/3T3: Selective techniques for isolation and biologic properties in yitro and in vivo. Virology 57:339–346
HartleyJ. W.,
RoweW. P.1966; Production of altered cell foci in tissue culture by defective Moloney sarcoma virus particles. Proceedings of the National Academy of Sciences of the United States of America 55:780–786
HatanakaM.,
KleinR.,
ToniR.,
WalkerJ.,
GildenR.1973; Mutants of nonproducer cell lines transformed by murine sarcoma viruses. I. Induction, isolation, particle production, and tumorigenicity. Journal of Experimental Medicine 138:356–363
HatanakaM.,
KleinR.,
LongC. W.,
GildenR.1973b; Mutants of nonproducer cell lines transformed by murine sarcoma virus. II. Relationship of tumorigenicity to presence– of viral markers and rescuable sarcoma genome. Journal of Experimental Medicine 138:364–372
InbarM.,
RabinowitzZ.,
SachsL.1969; The formation of variants with a reversion of properties of transformed cells. III. Reversion of the structure of the cell surface membrane. International Journal of Cancer 4:690–696
LowyD. R.,
RoweW. P.,
TeichN.,
HartleyJ. W.1971; Murine leukemia virus: High-frequency activation in vitro by 5-iododeoxyuridine and 5-bromodeoxyuridine. Science, New York 174:155–156
MarinG.,
MacphersonI.1969; Reversion in polyoma-transformed cells: Retransformation, induced antigens and tumorigenicity. Journal of Virology 3:146–149
NomuraS.,
FischingerP. J.,
MatternC. F. T.,
GerwinB. I.,
DunnK. J.1973b; Revertants of mouse cells transformed by murine sarcoma virus. II. Flat variants induced by fluorodeoxyuridine and colcemid. Virology 56:152–163
NomuraS.,
FischingerP. J.,
MatternC. F. T.,
PeeblesP. T.,
BassinR. H.,
FriedmanG. P.1972; Revertants of mouse cells transformed by murine sarcoma virus. I. Characterization of flat and transformed sublines without a rescuable murine sarcoma virus. Virology 50:51–64
O’ConnorT. E.1968; Quantitative in vitro studies on a murine sarcoma-leukemia virus complex. In Perspectives in Leukemia64–80 Edited by
DameshekW.,
DutcherR. M.
New York: Grune & Stratton;
PollackR. E.,
TeeborG. W.1969; Relationship of contact inhibition to tumor transplantability, morphology, and growth rate. Cancer Research 29:1770–1772
PollackR. E.,
GreenH.,
TodaroG. J.1968; Growth control in cultured cells: Selection of sublines with increased sensitivity to contact inhibition and decreased tumor-producing ability. Proceedings of the National Academy of Sciences of the United States of America 60:126–133
RabinowitzZ.,
SachsL.1969; The formation of variants with a reversion of properties of transformed cells. I. Variants from polyoma-transformed cells grown in vivo. Virology 38:336–342
StephensonJ. R.,
AaronsonS. A.1972; A genetic locus for inducibility of C-type virus in BALB/c cells: The effect of a nonlinked regulatory gene on detection of virus after chemical activation. Proceedings of the National Academy of Sciences of the United States of America 69:2798–2801
StephensonJ. R.,
ScolnickE. M.,
AaronsonS. A.1972; Genetic stability of the sarcoma viruses in murine and avian sarcoma virus-transformed nonproducer cells. International Journal of Cancer 9:577–583
StephensonJ. R.,
ReynoldsR. K.,
AaronsonS. A.1973; Characterization of morphologic revertants of murine and avian sarcoma virus-transformed cells. Journal of Virology 11:218–222
Revertants of Mouse Cells Transformed by Murine Sarcoma Virus: flat Variants without a Rescuable Sarcoma Virus from a Clone of BALB/3T3 Transformed by Kirsten MSV